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Abstract-In rat liver there appear to be significant differences between lobes in the concentration of 
individual cytochrome P-450 isozymes (Sumner and Lodola, Biochem Pharmacul36: 391-393, 1987). 
Because studies in patients often rely on small pieces of liver obtained from diverse anatomical locations, 
it seemed important to determine if the cytochromes P-450 were also heterogeneously distributed in 
human liver. Accordingly, tissue was obtained from ten different locations in a single human liver 
including those most commonly biopsied by percutaneous needles, and by surgeons during laparotomy. 
The differences observed between locations in the microsomal concentrations of carbon monoxide- 
binding protein (total cytochrome P-450), cytochrome b,, and NADPH-cytochrome P-450 reductase 
appeared to be small and were not statistically significant. Likewise, no significant differences were 
observed between locations in the specific content of HLp, HLp3, HLj, HLx or P450MP. However, the 
specific concentrations of WLd varied almost 2-fold between the microsomes and this was statistically 
significant in some cases (P < 0.05). Our results suggest that, in human livers, regional differences in 
the content of cytochromes P-450 are generaily small but may be signi~cant for some isozymes. With 
the exception of HM, tissue obtained by percutaneous or surgical hver biopsies is probably representative 
of the entire organ with regard to the enzymes assayed. 
The hepatic cytochromes P-450 are a multigene fam- 
ily of enzymes that play a critical role in the metab- 
olism of many drugs and xenobiotics. There are 
marked differences between patients in the liver 
content of some of the cytochromes P-450, and this 
may result in variable responses to many drugs and 
other xenobiotics [l]. These “oxidative polymor- 
phisms” appear to largely reflect genetic factors [l]; 
however, nongenetic factors may also be involved. 
In rodents, for example, it is well established that 
liver content and catalytic activity of some of the 
cytochromes P-450 are greatly influenced by animal 
gender and by treatment with a wide variety of 
xenobiotics, including many medications. Although 
many of the genes coding for rodent cytochromes P- 
450 have been shown to be highly conserved in 
other mammals including humans [2], it is generally 
unknown whether the mechanisms involved in the 
regulation of these enzymes are also highly 
conserved. If their regulation is conserved, the liver 
content of the cytochromes P-450 in patients could 
be influenced significantly by a variety of factors 
including many commoniy used medications, ciga- 
rette smoking, and gender. 
One approach to defining factors underlying cyto- 
chrome P-450 polymorphisms has been to examine 
individual P-450 proteins or their catalytic activities 
in liver tissue obtained from patients, and to correlate 
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these results with patient characteristics such as 
medication and smoking histories 13-91. In many 
instances, only a small portion of the patient’s liver 
is available for analysis, such as a small core of tissue 
obtained by percutaneous needle biopsy or a small 
wedge of tissue obtained during abdominal surgery, 
and it has been assumed that the information 
obtained from the samples on the expression of the 
cytochromes P-450 is representative of the entire 
liver. This assumption has been called into question 
by a recent report that the concentrations of total 
cytochrome P-450, and of the specific P-450 proteins 
inducible by phenobarbital and 3-methyl- 
cholanthrene, differ significantly in microsomes pre- 
pared from tissue obtained from different lobes, and 
from different locations within the same lobe of rat 
liver [lo, 111. If the distributions of the various forms 
of cytochrome P-450 in the human liver also vary 
depending on location within the liver, the results of 
analysis of tissue obtained from a single biopsy site 
may not be representative of the entire liver. 
We recently received an entire human liver from 
an adult male patient. Microsomes were prepared 
from tissue obtained at ten anatomical locations, 
including those most frequently biopsied. Each 
sample of microsomes was analyzed with regard to 
the concentration of five different human P-450 pro- 
teins, total cytochrome P-450, cytochrome bJ, and 
NADPH-cytochrome P-450 reductase activity. In 
addition, we assayed each sample of microsomes 
for its ability to catalyze the N-demethylation of 
erythromycin and N-nitroso-dimethylamine 
(NDMA), catalytic activities characteristic of HLp 
and of HLj respectively [3,5]. The results presented 
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here indicate that, within this liver. regional dif- 
ferences in content and activity of these enzymes 
generally appeared to be small. More importantly, 
tissue obtained from the most common locations 
for percutaneous and surgical (wedge) liver biopsies 
appeared to be representative of the entire organ 
with regard to all enzymes assayed, with the possible 
exception of HLd. 
METHODS 
Putient data. The entire liver was obtained from a 
30-year-old male patient who became an organ donor 
after he developed a subarachnoid hemorrhage. He 
had previously been healthy and he was not taking 
medications. Donor organ surgery was performed 
within 24 hr of his admission to the hospital and 20 hr 
after he was placed on a respirator. The patient’s 
serum aspartate aminotransferase. alanine amino- 
transferase, bilirubin. alkaline phosphatase, albumin 
and prothrombin time were all within normal limits. 
In the operating room the patient received 30,000 
units of intravenous heparin and dopamine (4pg/ 
kg/min) for 3 hr in addition to general anesthesia. 
The liver was rapidly cooled by in situ perfusion with 
a buffered saline and glucose solution (Eurocollins 
solution. 4”). The liver was then removed from the 
donor and transported on ice to a potential recipient 
at The University of Michigan Medical Center. The 
entire liver became available for our studies when 
the transplant recipient died intraoperatively and no 
alternate recipient could be found. The ten biopsies 
of liver tissue were obtained within 6 hr after removal 
of the liver from the donor. 
Tissue processing and preparation of microsomes. 
Wedges of hepatic tissue (- 10 g) were excised from 
the ten locations shown in Fig. 1. Location 6 is the 
most common site biopsied by percutaneous needle, 
and sites 2 and 4 are the most common locations for 
an intraoperative biopsy. All specimens were flash 
frozen in liquid nitrogen. Hepatic microsomes were 
prepared simultaneously from all tissue specimens 
as previously described 131. 
Antibodies and immunohlot anulyses. Antibodies 
that specifically recognize human cytochromes HLp 
[il. HLx 141. and HLd 1121 were prepared as 
described in the indicated references. Murine mono- 
clonal antibodies were prepared as previously 
described [4] against HLj [13] and P45OMP purified 
as indicated below. Immunoblot analyses were per- 
formed and quantified as previously described 141. 
Purification and characterization of human liver 
cytochrome P45OMP. Human liver microsomes 
(2000 mg) obtained from a patient previously termed 
patient 11 [4] were solubilized and the amino- 
octylamino-Sepharose 4B and diethylaminoethyl 
(DEAE)-cellulose columns were run as described in 
detail elsewhere [3]. The fractions in the second 
heme-containing peak eluting off the DEAE 
columns were combined and dialyzed against 30 vol. 
of buffer C (5 mM potassium phosphate, pH 6.5, 
20% glycerol, 0.1 mM EDTA, and 0.2% Tergitol 
NP-10) with three changes over 48 hr. The dialyzed 
sample was then applied at 1 mL/min to a CM-52 
column (1.6 X 28cm) equilibrated with 250mL of 
buffer C. The column was washed with 250mL of 
buffer C, and the hemoprotein was eluted by the 
application of 500 mL of 0 to 150 mM NaCl gradient 
in buffer C. Those fractions eluting in the major 
heme-containing peak were combined. 
The combined fractions were then dialyzed over- 
night against 50 vol. of 5 mM potassium phosphate 
(pH 7.25) buffer containing 20% glycerol. 0.1 mM 
EDTA, 0.1 mM dithiothreitol (DTT) and 0.2% Ter- 
gitol NP-10. The dialyzed sample was then applied at 
1 mL/min to an hydroxylapatite column (1.6 x 5 cm) 
equilibrated with 50 mL of the dialysis buffer. The 
column was then washed with SO mL each of 40 
and 90 mM potassium phosphate ( pH 7.25) buffers 
containing the same additives as the dialysis buffer. 
The combined fraction was then concentrated 3- 
fold and dialyzed against 125 vol. of 5 mM Tris-HCI 
buffer containing 20% glycerol, 1.OmM DTT. and 
1.0 mM EDTA with two changes over 2 days. The 
dialyzed fraction was then applied at I mL/min to 
a DEAE-Sepharose CL-6B column (I .6 x 7.5 cm) 
equilibrated with 100 mL of dialysis buffer. The 
hemoprotein did not bind tightly and was eluted with 
dialysis buffer. The detergent was removed from this 
fraction by application to a small hydroxylapatite 
column. 
The final fraction was found to contain only one 
protein as visualized in silver-stained sodium dodecyl 
sulfate (SDS)-polyacrylamide gels and had a CO- 
binding heme content of 14 nmol/mg protein. 
Amino-terminal amino acid analysis of P450MP by 
automated Edman degradation [5] yielded a 19 
amino acid sequence identical to that previously 
reported for the form of human liver P-450 respon- 
sible for the metabolism of mephenytoin and is there- 
fore presumed to be P450MP [14]. 
Statistical analysis. The determination of each 
enzyme activity or concentration was performed in 
triplicate on each of the ten samples of microsomes. 
For each enzyme, the results were subjected to a 
one-way analysis of variance followed by the Tukey 
multiple comparison procedure [15]. This analysis 
compared the three values obtained in microsomes 
from each location with the three values obtained in 
microsomes from each of the other nine locations. 
This conservative analysis was used to determine 
whether inconsistency in the assav procedures alone 
could account for the observed differences between 
liver locations. For each enzyme, the mean of values 
obtained at all ten locations was also calculated, 
and 95% confidence intervals were calculated as the 
mean ? two standard deviations of the mean. 
Other assays. Total cytochrome P-450 was 
measured as CO-binding protein [ 161. Cytochrome 
b, concentration [ 171, erythromycin N-demethylase 
activity 131, N-nitroso-dimethylamine N-demethyl- 
ase activity [5], and NADPH-cytochrome P-450 
reductase activity [lg] were measured as previously 
described at 37”. 
RESULTS 
Microsomes were prepared from tissue obtained 
at ten locations in a single human liver (Fig. 1). The 
levels of total CO-binding protein (total cytochrome 
P-450) and of cytochrome bS, and the activities of 
Cytochrome P-450 distribution in a human liver 
Fig. 1. Biopsy locations in the liver. Approximately 10 g of 
tissue was removed from each of the ten locations shown. 
The anterior of the liver is shown in the view obtained 
during laparotomy. Biopsies 8 and 9 were obtained from 
the opposite side of the liver. 
NADPH-cytochrome P-450 reductase, NDMA N- 
demethylase and erythromycin N-demethylase were 
determined in each sample of microsomes. The 
values obtained at each location are indicated in 
Table 1 as the means of triplicate measurements 
(except for cytochrome b,) with the calculated stand- 
ard deviations. Since each location was biopsied only 
once, the standard deviations shown for each 
location reflect the reproducibility of the assay results 
and not distribution of the enzyme within a specific 
region of the liver. 
To determine if the differences observed between 
locations could not have been due to inconsistencies 
in our assay methods alone, for each enzyme, the 
mean value obtained at each location was compared 
with that obtained at the other nine locations using 
the Tukey multiple comparison test [ 151. According 
to this conservative analysis, the difference between 
the lowest erythromycin N-demethylase activity 
(0.35 nmol/min/mg protein at location 7) and the 
highest catalytic activity towards this substrate 
(0.66nmol/min/mg protein in location 2) was 
significant (t = 5.11, P < 0.05). No other pairs of 
results from any of the other assays differed sig- 
nificantly, including the relatively large difference 
between the highest and lowest values for NADPH 
cytochrome P-450 reductase activity (141 at location 
1 and 212 at location 6; t = 4.96). The content of 
cytochrome bs varied from 0.441 nmol/mg (location 
9) to 0.493 nmol/mg (location 3); however, only two 
measurements were obtained in each specimen and 
the differences appeared to be within the error of 
the assay. Therefore, with one possible exception, 
the intraliver variations in the concentrations of the 
enzymes tested may not be significant. 
If the distribution of these enzymes is indeed 
homogeneous, the true liver specific concentration 
of each enzyme could be best estimated as the mean 
of the measurements obtained in biopsies from each 
of the ten locations. As shown in Table 1, the overall 
mean concentrations of cytochrome P-450 
(0.415 nmol/mg) and of cytochrome bs (0.471 nmol/ 
mg), and the overall mean NADPH reductase 
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Table 2. Distribution of specific isozymes of cytochrome P-450 in the human liver microsomes’ 
Location 
number HLp/HLp3 P450MP 
Isozymet 
HLx HLd HLj 
I 95 5 4 
2 94 t 4 
3 932 13 
4 114 2 15 
5 103 f 13 
6 104 ? Y 
7 109 + 4 
8 102 2 13 
9 95 + 2 
10 86-c 12 
Mean 99.5 ? 8.4 
95% Conf. intervals :82.7-l 16.3) 
76 t 1 
x4 t 9 
722 14 
93 -f 14 
87 2 8 
97 + 14 
83 * 3 
100 +- 15 
102 2 Y 
105 k 15 
89.92 11.2 
(67.4-l 12) 
69 k 6 
Xl + 11 
94 -+ 7 
X8 f 18 
71 ? 7 
94 c 9 
7124 
95 t 6 
77 I- 4 
106 5 12 
84.6 t 12.7 
(109-59.3) 
JO f 12 
46 2 2 
72 c 5 
42 t I 
62 t 6 
56 + 3 
7x + 2 
64 k 4 
77 t 3 
64 + 7 
60.1 k 13.9 
(32.4-87.8) 
105 t 16 
120 f IO 
100 + Y 
x4 + 8 
105 t 10 
109 t 1 
100 r 10 
106 f 9 
92 + 3 
94 t 1 
101.5 +- 10.0 
(121-81.5) 
* The levels of the various isozymes were determined by immunoblot analyses performed as described in Methods. 
The values are the means 2 SD of triplicate determinations. 
; All values are expressed as percent of immunoreactive protein present in microsomes from a unrelated patient 
(patient No. 23 in Ref. 4). 
(187 nmol/min/mg), erythromycin N-demethylase 
and NDMA N-demethylase (0.51 and 1.29 nmol for- 
maldehyde formed/min/mg respectively) activities 
are comparable to those previously reported in 
human liver microsomes [3,5,9]. The 95% con- 
fidence intervals of these means did not appear to 
be wide and, with the exception of the NADPH- 
cytochrome P-450 reductase activity determined at 
location 1, the result determined in the tissue from 
each location fell within the 95% confidence intervals 
of the mean for all locations. In particular. each 
assay value determined for tissue obtained from the 
locations of either a percutaneous biopsy (location 
6) or a surgical wedge biospy (location 2 and 4) fell 
within 20% of the respective mean determination for 
all locations. 
Next, we determined the distribution of five 
specific P-450 proteins in the liver by analyzing each 
of the ten samples of microsomes for content of 
immunoreactive HLp, P450MP, HLx, HLd, and 
HLj. This was determined by densitometric analysis 
of immunoblots developed with form specific anti- 
bodies. Each assay was performed in triplicate on 
each sample of microsomes, and the mean values + 
the standard deviations of the means are shown in 
Table 2. Our monoclonal antibody to HLp identified 
two closely spaced protein bands (a “doublet”) on 
the immunoblots, indicating that this patient 
expressed HLp3 [19]. HLp3 is a cytochrome P-450 
closely related to HLp in structure and catalytic 
activity, and it appears to be expressed in only 20% 
of the population [19]. The specific content listed in 
Table 2, therefore, reflects the combined total of 
these proteins. However, by visual inspection of 
the blots, there was no obvious difference between 
locations in the relative intensities of the HLp and 
HLp3 bands. The intraliver variations observed in 
HLp/HLp3, HLj, HLx and P450MP were not 
significant according to the Tukey multiple com- 
parison test. However, significant differences in the 
concentrations of HLd were observed between 
location 1 and locations 3, 7, 8, 9 and 10 (t = 7.19, 
8.85, 5.39, 8.32 and 5.39 respectively, P < 0.05). 
between locations 2 and 9 (t = 6.97, P < 0.05). 
between locations 3 and 4 (t = 6.74, P < 0.05), and 
between location 4 and locations 7 and 9 (t = 8.09 
and 7.87 respectively, P < 0.05). For each form of 
P-450 assayed, the specific content determined in 
microsomes prepared from each location fell within 
two standard deviations of the mean of measure- 
ments at all locations (Table 2). With the exception 
of HLd, the concentrations of each of the proteins 
determined in microsomes prepared from locations 
2, 4 and 6 fell within 20% of the mean values for all 
determinations. 
Finally, we reasoned that if the differences 
between locations in the concentrations of HLp/ 
HLp3 and HLj were in fact significant, we might see 
a correlation between the content of each enzyme 
protein and its characteristic catalytic activity in each 
sample of microsomes. However, no correlation was 
observed between the specific concentrations of 
HLp/HLp3 and the ability to demethylate erythro- 
mycin (r = 0.08) or between the specific con- 
centration of HLj and the ability to catalyze NDMA 
demethylation (r = 0.03). This suggests that the 
distribution of these forms and their catalytic activi- 
ties were uniform across the ten sites examined. 
DISCUSSION 
It is now well established that within the functional 
unit of mammalian liver. the hepatic acinus, hepa- 
tocyte content of drug-metabolizing enzymes is het- 
erogenous [20]. It has been reported recently that, in 
addition to acinar heterogeneity, there are significant 
interlobe and intralobe variations in the microsomal 
concentration of total cytochrome P-450 and of P- 
450 proteins in rat liver [lo, 111. Similar regional 
differences in human liver may have important impli- 
cations since it is rarely possible to obtain a whole 
human liver for analysis, and studies often rely on 
small amounts of tissue obtained from diverse ana- 
tomical locations. 
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We here report the results of assays of various 
enzyme activities and of five P-450 proteins in micro- 
somes prepared from ten different locations of an 
entire adult male liver. In general, intraliver dif- 
ferences in the content and catalytic activity of the 
enzymes measured appeared to be small. Indeed, the 
conservative multiple analysis statistics we employed 
suggested that the majority of these differences could 
have been due to inconsistency in our assay methods 
alone. Additional evidence suggesting that the 
specific concentration of some of the drug metab- 
olizing enzymes may be homogeneous in human liver 
is that there was no correlation between either the 
content of HLp/HLp3 and erythromycin N- 
demethylase activity or between the content of HLj 
and NDMA N-demethylase activity in the micro- 
somes. We have shown previously that in human 
liver microsomes anti-HLp IgG can inhibit >95% of 
the erythromycin N-demethylase activity present and 
anti-HLj IgG can inhibit up to 78% of the NDMA N- 
demethylase activity [5,21]. Furthermore, we have 
demonstrated that, in microsomes isolated from a 
large number of different human liver specimens, an 
excellent correlation exists between the content of 
HLp and HLj and their respective catalytic activities 
[3,21, and unpublished results]. Our failure to find 
these correlations in the liver microsomes of our 
patient further suggests that the regional differences 
in the concentrations of these enzymes may not be 
significant. 
Differences between microsomes in content of 
HLd appeared to be significant, however. Thus, a 
study of this patient which relied exclusively on 
measurements of HLd determined in tissue obtained 
by surgical biopsy in location 2 or 4 would have 
underestimated the mean value for all locations of 
this liver by almost 30% (Table 2). This suggests 
that the distribution of HLd in this liver may be 
independent of that of other cytochromes P-450, 
which appeared to be homogeneous in the liver. 
It has been reported that treatment of rats with 
phenobarbital or 3-methylcholanthrene increases 
interlobe differences in the distribution of the 
induced P-450 proteins [ll]. The selective variation 
in concentration of HLd therefore may have resulted 
from exposure of this patient to inducers of this 
enzyme. However, our patient had received no 
known enzyme inducers prior to surgery, he was 
not a smoker, and he had no history of unusual 
environmental exposures. Furthermore, the specific 
content of HLd in the liver microsomes of our patient 
was similar to that observed in the majority of the 
other livers we have assayed (41. It was not possible to 
confirm the differences in HLd protein by correlating 
them with differences in catalytic activity since an 
HLd-specific substrate has not yet been identified. It 
should be pointed out, however, that the regional 
differences observed in the specific content of HLd 
are modest compared to the greater than lo-fold 
variation in liver HLd concentration observed 
between patients [4]. It would obviously be desirable 
to repeat our studies in additional whole livers 
obtained from patieuts with a variety of medication 
and environmental exposure histories, but this will 
be difficult with the current demand for transplant 
organs. 
In summary, intraliver differences in the content of 
the measured enzyme proteins and catalytic activities 
were generally small in this patient. With the excep- 
tion of HLd concentration, the results of each assay 
performed on tissue obtained from the most common 
sites for percutaneous liver biopsy or for surgical 
wedge liver biopsy were within 20% of the mean 
value for all locations. 
Acknowledgements-This research was supported by 
National Institutes of Health Grants GM 38149 and GM 
37598. P. B. W. is a recipient of a Research Associate 
Career Development award from the Veterans Adminis- 
tration. 
REFERENCES 
1. Jacqz E, Hall SD and Branch RA, Genetically deter- 
mined polymorphisms in drug oxidation. Hepafology 
6: 1020-1032, 1986. 
2. Nebert DW, Adesnik M, Coon MJ, Estabrook RW, 
Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson 
EF, Kemper B, Levin W, Phillips IR, Sato R and 
Waterman MR, The P450 gene superfamily: rec- 
ommended nomenclature. DNA 6: l-11, 1987. 
3. Watkins PB, Wrighton SA, Maurel P, Schuetz EG, 
Mendez-Picon G, Parker GA and Guzelian PS, Identi- 
fication of an inducible form of cytochrome P-450 in 
human liver. Proc Natl Acad Sci USA 8: 6310-6314, 
1985. 
4. Wrighton SA, Thomas PE, Willis P, Maines SL, Wat- 
kins PB, Levin W and Guzelian PS, Purification of 
a human liver cytochrome P-450 immunochemically 
related to several cytochromes P-450 purified from 
untreated rats. J Clin Invest 80: 1017-1022, 1987. 
5. Wrighton SA, Thomas PE, Molowa DT, Haniu M, 
Shively JE, Maines SL, Watkins PB, Parker G, Mend- 
ez-Picon G. Levin W and Guzelian PS. Char- 
acterization of ethanol-inducible human liver N- 
nitrosodimethylamine demethylase. Biochemistry 25: 
6731-6735, 1986. 
6. Boobis AR, Murray S, Seddon CE and Davies DS, 
In vitro studies of induction and inhibition of drug 
oxidation in man. Pharmacol Ther 33: 101-108, 1987. 







and Leroux JP, Induction of drug-metabolizing 
enzymes by tricyclic antidepressants in human liver: 
characterization and partial resolution of cytochromes 
P-450. Br J Clin Pharmacol 16: 651-657, 1983. 
Remmer H, Schoene B and Fleischmann RA, Induc- 
tion of the unspecific microsomal hydroxylase in the 
human liver. Drug Merab Dispos 1: 224-230, 1973. 
Boobis AR, Brodie MJ, Kahn GC, Fletcher DR, Saun- 
ders JH and Davies DS, Monooxygenase activity of 
human liver in microsomal fractions of needle biopsy 
specimens. Br J Clin Pharmacol9: 11-19, 1980. 
Matsubata T, Touchi A and Ogawa A, Heterogeneous 
distribution of the cytochrome P-450 monooxygenase 
system in rat liver lobes. Jpn J Pharmacol 32: 999- 
1011, 1982. 
Sumner IG and Lodola A, Total cytochrome P-450, but 
not the major phenobarbitone or 3-methylcholanthrene 
induced isoenzyme, is differently induced in the lobes 
of the rat liver. Biochem Pharmacol36: 391-393,1987. 
Wrighton SA, Campanile C, Thomas PE, Maines SL, 
Watkins PB, Parker G, Mendez-Picon G, Haniu M, 
Shively JE, Levin W and Guzelian PS, Identification 
of a human liver cytochrome P-450 homologous to the 
major isosafrole-inducible cytochrome P-450 in the rat. 
Mol Pharmacol29: 405-410, 1986. 
Wrighton SA, Thomas PE, Ryan DE and Levin W, 
Purification and characterization of ethanol-inducible 
476 P. B. WATKINS et al 
human hepatic cytochrome P-450HLj. Arch Biochem 
Biophys 258: 292-297. 1987. 
14. Shimada T. Misono KS and Guengerich FP, Human 
liver microsomal cytochrome P-450 mephenytoin 4- 
hydroxylase. a prototype of genetic polymorphism in 
oxidative drug metabolism. Purification and char- 
actcrization of two similar forms involved in the 
reaction. J Biol Chem 261: 909-921. 1986. 
15. Neter J. Wasserman W and Kutner MH. Single factor 
analysis of variance. Applied Linear Statistical Models, 
2nd Edn. pp. X+601. Irwin Publishers, Irwin, NW. 
1985. 
16. Omura T and Sato R, The carbon monoxide-binding 
pigment of liver microsomes. II. Solubilization. puri- 
fication and properties. J Biol Chem 239: 2379-2385. 
1961. 
17. Kajihara T and Hagihara B. Crystalline cytochrome 6,. 
I. Purification of crystalline cytochromes 0, from rabbit 
liver. J Biochem (Tokyo) 63: 453461. 19h8. 
18. Maze1 P, Experiments illustrating drug metabolism irz 
vitro. In: Fundamentals of Drug Metabolism crud Drug 
Disposition (Eds. La Du BN. Mandcl HG and Way 
EL), pp. 54&582. Williams Kr Wilkins. Baltimore. 
1971. 
19. Wrighton SA, Ring BJ. Watkins PB and Vander-Bran- 
den M. Identification of a polymorphically expressed 
member of the human cytochromc P--150 III family. 
Mel Pharmacol36: 97-105. 1989. 
20. Traber PG, Chianale J and Gumucio JJ. Physiological 
significance and regulation of heoatocellular het- 
erogeneity. Gastroenierology 95: I iicrl143, 198X. 
21. Watkins PB, Murrav SA. Winkelman LG. Heuman 
DM. Wrighton SA ‘and Guzelian PS. Erythromvcm 
breath test as an assay of glucocorticoid-inducible hver 
cytochromes P-450. J C/in Inrwst 83: 688-697. 19XY. 
